We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDC icon
3551
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$740M
$1K ﹤0.01%
41
-79
-66% -$2.79K
CIEN icon
3552
Ciena
CIEN
$56.1B
$1K ﹤0.01%
42
-163
-80% -$3.79K
CIK
3553
Credit Suisse Asset Management Income Fund
CIK
$134M
$1K ﹤0.01%
200
+184
+1,150% +$545
CIX icon
3554
Comp X International
CIX
$373M
$1K ﹤0.01%
47
-249
-84% -$2.79K
CPAC
3555
Cementos Pacasmayo
CPAC
$1.02B
$1K ﹤0.01%
193
-2,052
-91% -$18K
CPHC icon
3556
Canterbury Park Holding Corp
CPHC
$79.6M
$1K ﹤0.01%
100
-452
-82% -$4.7K
CRD.A icon
3557
Crawford & Co Class A
CRD.A
$642M
$1K ﹤0.01%
251
+144
+135% +$943
CTSO icon
3558
Cytosorbents Corp
CTSO
$23.3M
$1K ﹤0.01%
160
-41
-20% -$273
CVR icon
3559
Chicago Rivet & Machine Co
CVR
$10.1M
$1K ﹤0.01%
33
-393
-92% -$10.4K
CXH
3560
DELISTED
MFS Investment Grade Municipal Trust
CXH
$1K ﹤0.01%
+56
New +$538
CYTK icon
3561
Cytokinetics
CYTK
$10.4B
$1K ﹤0.01%
+174
New +$1.19K
DAC icon
3562
Danaos Corp
DAC
$2.53B
$1K ﹤0.01%
15
-75
-83% -$6.32K
DHT icon
3563
DHT Holdings
DHT
$2.98B
$1K ﹤0.01%
84
-13,066
-99% -$101K
DRRX
3564
DELISTED
DURECT Corp
DRRX
$1K ﹤0.01%
70
-1,414
-95% -$32.2K
DY icon
3565
Dycom Industries
DY
$12.2B
$1K ﹤0.01%
20
-4,772
-100% -$330K
ECNS icon
3566
iShares MSCI China Small-Cap ETF
ECNS
$67.1M
$1K ﹤0.01%
+30
New +$1.36K
ENX
3567
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$1K ﹤0.01%
45
-54
-55% -$673
ERH
3568
Allspring Utilities & High Income Fund
ERH
$103M
$1K ﹤0.01%
63
+57
+950% +$635
EVGN icon
3569
Evogene
EVGN
$7.67M
$1K ﹤0.01%
10
-5
-33% -$435
EVM
3570
DELISTED
Eaton Vance California Municipal Bond Fund
EVM
$1K ﹤0.01%
46
-56
-55% -$643
EXAS
3571
DELISTED
Exact Sciences
EXAS
$1K ﹤0.01%
65
-1,786
-96% -$41K
FATE icon
3572
Fate Therapeutics
FATE
$322M
$1K ﹤0.01%
+160
New +$1.09K
FBIO icon
3573
Fortress Biotech
FBIO
$90M
$1K ﹤0.01%
17
-336
-95% -$15.7K
FBP icon
3574
First Bancorp
FBP
$4.41B
$1K ﹤0.01%
400
-30,748
-99% -$125K
FCG icon
3575
First Trust Natural Gas ETF
FCG
$644M
$1K ﹤0.01%
20
-8,428
-100% -$293K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.